183 related articles for article (PubMed ID: 34898548)
1. Contribution of the Idylla
Petiteau C; Robinet-Zimmermann G; Riot A; Dorbeau M; Richard N; Blanc-Fournier C; Bibeau F; Deshayes S; Bergot E; Gervais R; Levallet G
Curr Oncol; 2021 Nov; 28(6):4432-4445. PubMed ID: 34898548
[TBL] [Abstract][Full Text] [Related]
2. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
[TBL] [Abstract][Full Text] [Related]
3. Idylla
Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
[TBL] [Abstract][Full Text] [Related]
4. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Idylla system to detect the EGFR
Bocciarelli C; Cohen J; Pelletier R; Tran Van Nhieu J; Derman J; Favre L; Bourgogne A; Monnet I; Chouaid C; Pujals A
Pathol Res Pract; 2020 Jan; 216(1):152773. PubMed ID: 31836323
[TBL] [Abstract][Full Text] [Related]
6. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fast and fully automated platform to diagnose
Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
[TBL] [Abstract][Full Text] [Related]
8. Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Momeni-Boroujeni A; Salazar P; Zheng T; Mensah N; Rijo I; Dogan S; Yao J; Moung C; Vanderbilt C; Benhamida J; Chang J; Travis W; Rekhtman N; Ladanyi M; Nafa K; Arcila ME
J Mol Diagn; 2021 Mar; 23(3):310-322. PubMed ID: 33346146
[TBL] [Abstract][Full Text] [Related]
9. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla
Boustany Y; Laraqui A; El Zaitouni S; Ghaouti M; Benzekri A; Kettani F; Oukabli M; Ennibi K; Belkadi B; Sekhsokh Y
Cancer Control; 2023; 30():10732748231177538. PubMed ID: 37196225
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
[TBL] [Abstract][Full Text] [Related]
11. [EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
Chevalier LM; Billaud A; Passot C; Renoult A; Bigot F; Verrièle V; Morel A
Ann Pathol; 2020 Sep; 40(5):389-400. PubMed ID: 32081549
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
[TBL] [Abstract][Full Text] [Related]
13. Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform.
Banyi N; Alex D; Hughesman C; McNeil K; N Ionescu D; Ma C; Yip S; Melosky B
Curr Oncol; 2022 Oct; 29(10):7900-7911. PubMed ID: 36290901
[TBL] [Abstract][Full Text] [Related]
14. Is the Idylla
De Luca C; Conticelli F; Leone A; Gragnano G; Salatiello M; Galasso P; Pisapia P; Grillo LR; Iaccarino A; Vigliar E; Bellevicine C; Malapelle U; Troncone G
J Clin Pathol; 2019 Sep; 72(9):609-614. PubMed ID: 31110050
[TBL] [Abstract][Full Text] [Related]
15. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
[TBL] [Abstract][Full Text] [Related]
16. Advanced non-small cell lung cancer: Rapid evaluation of EGFR status on fine-needle cytology samples using Idylla.
D'Ardia A; Caputo A; Fumo R; Ciaparrone C; Gaeta S; Picariello C; Zeppa P; D'Antonio A
Pathol Res Pract; 2021 Aug; 224():153547. PubMed ID: 34280752
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.
Grant J; Stanley A; Balbi K; Gerrard G; Bennett P
J Clin Pathol; 2022 Apr; 75(4):241-249. PubMed ID: 33514586
[TBL] [Abstract][Full Text] [Related]
18. Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples.
Hawkins P; Stevenson T; Powari M
Am J Clin Pathol; 2021 Sep; 156(4):653-660. PubMed ID: 33877290
[TBL] [Abstract][Full Text] [Related]
19. Ultrarapid
Arcila ME; Yang SR; Momeni A; Mata DA; Salazar P; Chan R; Elezovic D; Benayed R; Zehir A; Buonocore DJ; Rekhtman N; Lin O; Ladanyi M; Nafa K
JTO Clin Res Rep; 2020 Sep; 1(3):. PubMed ID: 33511359
[TBL] [Abstract][Full Text] [Related]
20. Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing.
Nkosi D; Casler VL; Syposs CR; Oltvai ZN
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
